1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow NUT Midline Carcinoma (NMC): new trials by email Literature Review of NUT Midline Carcinoma (NMC) trials Research Report on NUT Midline Carcinoma (NMC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) Birabresib - NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC) | Phase 1 | Terminated | Merck Sharp & Dohme LLC | 13 | 2016-05-04 | 2021-01-27 |
Carcinoma, Non-Small-Cell Lung (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Thoracic Neoplasms (1)
OTX015 (1)
2015 (1)